AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitascore-M 1000/50 Tablet

Prescription Icon
Prescription Required

Marketer

Chinar Therapeutics Pvt.&Ltd.

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitascore-M 1000/50 Tablet

Combiflex-D 1000/50 is a dual-action tablet managing elevated blood glucose in type 2 diabetes patients. This dual therapy helps avert serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Combiflex-D 1000/50 may be used independently or in conjunction with other antidiabetic treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical guidance. Adherence to your prescribed diet and exercise plan is crucial for diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Low blood sugar (hypoglycemia) is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to recognize and manage this risk. This medication isn't universally suitable. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before use. Pregnant or lactating individuals require medical consultation prior to use. Drug interactions are possible; disclose all medications to your doctor for safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor your renal function and blood sugar levels throughout treatment.

Uses of Sitascore-M 1000/50 Tablet

Managing type 2 diabetes

Major Benefits of Sitascore-M 1000/50 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sitascore-M 1000/50 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitascore-M 1000/50 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitascore-M 1000/50 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitascore-M 1000/50 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Sitascore-M 1000/50 Tablet works:

Sitascore-M 1000/50 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Sitascore-M 1000/50 tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitascore-M 1000/50 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitascore-M 1000/50 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitascore-M 1000/50 tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. For individuals with severe kidney disease, Sitascore-M 1000/50 tablets are contraindicated. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitascore-M 1000/50 Tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitascore-M 1000/50 Tablet :

Should you forget a Sitascore-M 1000/50 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitascore-M 1000/50 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitascore-M 1000/50 Tablet

Sitascore-M 1000/50 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitascore-M 1000/50 Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia and neurological issues, potentially resulting in numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 intake is recommended annually, according to some researchers.
Sitascore-M 1000/50 Tablet may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitascore-M 1000/50 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitascore-M 1000/50 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitascore-M 1000/50) can rarely cause lactic acidosis (MALA), a serious medical emergency involving excess blood lactic acid. This risk is higher in patients with kidney disease, older adults, and heavy alcohol users, so it's avoided in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Sitascore-M 1000/50 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitascore-M 1000/50 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitascore-M 1000/50 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitascore-M 1000/50 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (like Sitascore-M 1000/50 Tablet) can cause lactic acidosis, a serious, potentially life-threatening buildup of lactic acid in the blood (also known as MALA, Metformin-associated lactic acidosis). This rare side effect is more likely in individuals with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitascore-M 1000/50 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency can cause anemia and neurological issues, manifesting as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and impaired balance. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Sitascore-M 1000/50 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitascore-M 1000/50 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitascore-M 1000/50 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitascore-M 1000/50 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (like Sitascore-M 1000/50 Tablet) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitascore-M 1000/50 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency can cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitascore-M 1000/50 Table...
168
MRP 195
13% off